Skip to main content
. 2022 Apr 25;13:838435. doi: 10.3389/fphys.2022.838435

FIGURE 5.

FIGURE 5

Evaluation of Cardiac Hazard Risk of Nineteen Reference Drugs in Two iCell-Cardiomyocytes2 Lots (12012 and 105091) and one iCell Cardiomyocyte Lot (103674). Reference drugs were scored for cardiac hazard using the described scoring matrix. “no TdP risk,” “TdP risk,” and “other mechanism” groups represent drug categories based on FDA labels for marketed drugs.